Techno Medica Statistics
Total Valuation
Techno Medica has a market cap or net worth of JPY 14.78 billion. The enterprise value is 6.34 billion.
Important Dates
The last earnings date was Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Mar 30, 2027 |
Share Statistics
Techno Medica has 6.97 million shares outstanding. The number of shares has decreased by -3.10% in one year.
| Current Share Class | 6.97M |
| Shares Outstanding | 6.97M |
| Shares Change (YoY) | -3.10% |
| Shares Change (QoQ) | -2.96% |
| Owned by Insiders (%) | 34.53% |
| Owned by Institutions (%) | 11.85% |
| Float | 3.44M |
Valuation Ratios
The trailing PE ratio is 11.99.
| PE Ratio | 11.99 |
| Forward PE | n/a |
| PS Ratio | 1.28 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.12 |
| P/FCF Ratio | 7.96 |
| P/OCF Ratio | 7.69 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 3.24, with an EV/FCF ratio of 3.42.
| EV / Earnings | 5.34 |
| EV / Sales | 0.55 |
| EV / EBITDA | 3.24 |
| EV / EBIT | 3.39 |
| EV / FCF | 3.42 |
Financial Position
The company has a current ratio of 6.75, with zero debt.
| Current Ratio | 6.75 |
| Quick Ratio | 5.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.68% and return on invested capital (ROIC) is 26.38%.
| Return on Equity (ROE) | 8.68% |
| Return on Assets (ROA) | 7.29% |
| Return on Invested Capital (ROIC) | 26.38% |
| Return on Capital Employed (ROCE) | 13.83% |
| Weighted Average Cost of Capital (WACC) | 5.80% |
| Revenue Per Employee | 48.47M |
| Profits Per Employee | 4.97M |
| Employee Count | 239 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.28 |
Taxes
In the past 12 months, Techno Medica has paid 527.00 million in taxes.
| Income Tax | 527.00M |
| Effective Tax Rate | 30.73% |
Stock Price Statistics
The stock price has increased by +9.56% in the last 52 weeks. The beta is 0.28, so Techno Medica's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +9.56% |
| 50-Day Moving Average | 2,068.40 |
| 200-Day Moving Average | 2,163.66 |
| Relative Strength Index (RSI) | 50.74 |
| Average Volume (20 Days) | 13,700 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Techno Medica had revenue of JPY 11.59 billion and earned 1.19 billion in profits. Earnings per share was 176.93.
| Revenue | 11.59B |
| Gross Profit | 5.44B |
| Operating Income | 1.87B |
| Pretax Income | 1.72B |
| Net Income | 1.19B |
| EBITDA | 1.96B |
| EBIT | 1.87B |
| Earnings Per Share (EPS) | 176.93 |
Full Income Statement Balance Sheet
The company has 8.44 billion in cash and no debt, with a net cash position of 8.44 billion or 1,211.07 per share.
| Cash & Cash Equivalents | 8.44B |
| Total Debt | n/a |
| Net Cash | 8.44B |
| Net Cash Per Share | 1,211.07 |
| Equity (Book Value) | 13.22B |
| Book Value Per Share | 2,045.23 |
| Working Capital | 11.37B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 1.92 billion and capital expenditures -65.00 million, giving a free cash flow of 1.86 billion.
| Operating Cash Flow | 1.92B |
| Capital Expenditures | -65.00M |
| Depreciation & Amortization | 88.00M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.86B |
| FCF Per Share | 266.38 |
Full Cash Flow Statement Margins
Gross margin is 46.96%, with operating and profit margins of 16.13% and 10.25%.
| Gross Margin | 46.96% |
| Operating Margin | 16.13% |
| Pretax Margin | 14.80% |
| Profit Margin | 10.25% |
| EBITDA Margin | 16.89% |
| EBIT Margin | 16.13% |
| FCF Margin | 16.02% |
Dividends & Yields
This stock pays an annual dividend of 68.00, which amounts to a dividend yield of 3.21%.
| Dividend Per Share | 68.00 |
| Dividend Yield | 3.21% |
| Dividend Growth (YoY) | -24.81% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 72.31% |
| FCF Payout Ratio | 36.41% |
| Buyback Yield | 3.10% |
| Shareholder Yield | 6.31% |
| Earnings Yield | 8.34% |
| FCF Yield | 12.56% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
The last stock split was on September 26, 2013. It was a forward split with a ratio of 300.
| Last Split Date | Sep 26, 2013 |
| Split Type | Forward |
| Split Ratio | 300 |
Scores
Techno Medica has an Altman Z-Score of 7.45 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.45 |
| Piotroski F-Score | 6 |